Cleared Traditional

K761281 - DATA-TOPE T3 UPTAKE PROCEDURE

K761281 is an FDA 510(k) clearance for DATA-TOPE T3 UPTAKE PROCEDURE, manufactured by Dade, Baxter Travenol Diagnostics, Inc.. The device is a Class 2 Chemistry device with product code KHQ cleared through the Traditional 510(k) pathway after a 51-day FDA review.

K761281 · Dade, Baxter Travenol Diagnostics, Inc. · Chemistry device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Feb 1977
Decision
51d
Days
Class 2
Risk

K761281 is an FDA 510(k) clearance for the DATA-TOPE T3 UPTAKE PROCEDURE. Classified as Radioassay, Triiodothyronine Uptake (product code KHQ), Class II - Special Controls.

Submitted by Dade, Baxter Travenol Diagnostics, Inc. (Mchenry, US). The FDA issued a Cleared decision on February 9, 1977 after a review of 51 days - a notably fast clearance cycle.

This device falls under the Chemistry FDA review panel, regulated under 21 CFR 862.1715 - the FDA in vitro diagnostics and chemistry framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Fast-track predicate clearance. Standard predicate reliance. The short review cycle indicates strong predicate alignment - the FDA found sufficient equivalence without extended technical review.

View all Dade, Baxter Travenol Diagnostics, Inc. devices

FDA 510(k) Submission Details - K761281

510(k) Number K761281 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received December 20, 1976
Decision Date February 09, 1977
Days to Decision 51 days
Submission Type Traditional
Review Panel Chemistry (CH)
Summary -
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
37d faster than avg
Panel avg: 88d · This submission: 51d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

KHQ Device Classification - Class 2, Special Controls

Product Code KHQ Radioassay, Triiodothyronine Uptake
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 862.1715
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Chemistry devices follow this clearance model.

Regulatory Peers - KHQ Radioassay, Triiodothyronine Uptake

All 73
Devices cleared under the same product code (KHQ) and FDA review panel - the closest regulatory comparables to K761281.
PHADEBAS T3 U TEST
K771078 · Pharmacia, Inc. · Jun 1977
T3 UPTAKE REAGENT SET
K770845 · The Dow Chemical Co. · May 1977
IN VITRO T-3 UPTAKE TEST
K770480 · Clinical Assays, Inc. · Apr 1977
SPAC TM T3 UPTAKE KIT
K770033 · Mallinckrodt Critical Care · Feb 1977
T-3 UPTAKE KIT
K760802 · Diagnostic Products Corp. · Oct 1976